{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:06:48Z","timestamp":1793390808299,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jpurol.2020.07.020","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T12:06:24Z","timestamp":1595419584000},"page":"655.e1-655.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and safety of Mirabegron as adjuvant treatment in children with refractory neurogenic bladder dysfunction"],"prefix":"10.1016","volume":"16","author":[{"given":"Cristian","family":"Sager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianela","family":"Sanmartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Burek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesica Ruth","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Vazquez Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Lopez Imizcoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Tessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Szklarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2020.07.020_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5173\/ceju.2015.01.494","article-title":"Quality of life related to urinary continence in adult spina bifida patients","volume":"68","author":"Liu","year":"2015","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-008-0780-7","article-title":"Treatment of the neurogenic bladder in spina bifida","volume":"23","author":"De Jong","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-5347(05)64112-2","article-title":"Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup","volume":"169","author":"Hopps","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2020.07.020_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/20469047.2017.1351745","article-title":"The management of paediatric neurogenic bladder: an approach in a resource-poor setting","volume":"37","author":"Maison","year":"2017","journal-title":"Paediatr Int Child Health"},{"issue":"3","key":"10.1016\/j.jpurol.2020.07.020_bib5","doi-asserted-by":"crossref","first-page":"271.e1","DOI":"10.1016\/j.jpurol.2016.12.024","article-title":"Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele","volume":"13","author":"Sager","year":"2017","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/toxins5010016","article-title":"Onabotulinumtoxin A for treating overactive\/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningocele","volume":"5","author":"Marte","year":"2013","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.jpurol.2020.07.020_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-013-3365-x","article-title":"Repeated injections of intradetrusor onabotulinumtoxinA as adjunctive treatment of children with neurogenic bladder","volume":"30","author":"Sager","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpurol.2020.07.020_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4`-(2-hydroxyl-2-phenylenthyl)amino)ethyl)acetanilide (YM178), a novel selective beta3- adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jpurol.2020.07.020_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/nau.22783","article-title":"International children's continence society standardization report on urodynamic studies of the lower urinary tract in children","volume":"34","author":"Bauer","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2020.07.020_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children's continence society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2020.07.020_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients; a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-5347(05)64112-2","article-title":"Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup","volume":"169","author":"Hopps","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.eururo.2015.07.071","article-title":"Summary of European association of Urology guidelines on neuro-urology","volume":"69","author":"Groen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/nau.22248","article-title":"International children's continence society's recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children","volume":"31","author":"Rawashdeh","year":"2012","journal-title":"Neurourol Urodyn"},{"issue":"Suppl.2","key":"10.1016\/j.jpurol.2020.07.020_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1464-410X.83.s2.3.x","article-title":"Factors involved in the success of antimuscarinic treatment","volume":"83","author":"Abrams","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2020.07.020_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(17)32480-1","article-title":"Non- surgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele","volume":"152","author":"Hernandez","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ucl.2018.06.005","article-title":"Neuropathic bladder and augmentation cystoplasty","volume":"45","author":"Roth","year":"2018","journal-title":"Urol Clin"},{"key":"10.1016\/j.jpurol.2020.07.020_bib18","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1111\/bph.14121","article-title":"Mirabegron: potential off target effects and uses beyond the bladder","volume":"175","author":"Dehvari","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sc.2015.195","article-title":"Initial experience with the treatment of neurogenic detrusor overactivity with a new B-3 agonist (Mirabegron) in patients with spinal cord injury","volume":"54","author":"Wollner","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jpurol.2020.07.020_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eururo.2016.02.007","article-title":"Prospective pilot study of Mirabegron in pediatric patients with overactive bladder","volume":"70","author":"Blais","year":"2016","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.jpurol.2020.07.020_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00345-018-2576-0","article-title":"Efficacy and safety of Mirabegron, a B3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study","volume":"37","author":"Park","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.jpurol.2020.07.020_bib22","first-page":"1","article-title":"Efficacy and safety of Mirabegron for the treatment of neurogenic detrusor overactivity. Prospective, randomized, doble-blin-controlled study","author":"Krhut","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.jpurol.2020.07.020_bib23","doi-asserted-by":"crossref","first-page":"31.e1","DOI":"10.1016\/j.jpurol.2019.10.009","article-title":"The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation","volume":"16","author":"Rittig","year":"2019","journal-title":"J Pediatr Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120304319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120304319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:49:41Z","timestamp":1761486581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513120304319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1477513120304319"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.07.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738524206.793579480","asserted-by":"object"}]},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Mirabegron as adjuvant treatment in children with refractory neurogenic bladder dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}